CARLSBAD, Calif., March 24, 2026--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf ...
In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...
The Israel-Iran war is escalating across several fronts, with assassinations of senior Iranian officials, and Israeli and Iranian attacks on key energy infrastructure. On day 20 of the conflict, ...
Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression 14-Month Follow-up Data Show Hypoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results